Entrada Therapeutics, Inc. (TRDA) Reports Q2 Loss, Lags Revenue Estimates

Entrada Therapeutics, Inc. (TRDA) came out with a quarterly loss of $1.04 per share versus the Zacks Consensus Estimate of a loss of $0.86. This compares to earnings of $1.55 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -20.93%. A quarter ago, it was expected that this company would post a loss of $0.78 per share when it actually produced a loss of $0.42, delivering a surprise of +46.15%.Over the last four quarters, the com ...